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Diagnostic difﬁ   culties may have led to underestima-
tion of rhinovirus infections in long-term care facilities. Us-
ing surveillance data, we found that rhinovirus caused 59% 
(174/297) of respiratory outbreaks in these facilities during 
6 months in 2009. Disease was sometimes severe. Molecu-
lar diagnostic testing can differentiate these outbreaks from 
other infections such as inﬂ  uenza.
R
espiratory tract illnesses are a major cause of illness 
and death among elderly persons, especially those in 
long-term care facilities. Although the most commonly 
identiﬁ  ed viruses have been inﬂ  uenza virus and respiratory 
syncytial virus (RSV) (1), human rhinovirus (HRV) is be-
ing increasingly associated with severe respiratory disease 
and outbreaks in these facilities (2–6). Clinical diagnosis 
of HRV by immunoﬂ   uorescence and virus culture has 
been difﬁ  cult because these methods are unreliable (7,8). 
Moreover, because multiple serotypes of HRV exist, ret-
rospective serologic testing cannot be used to evaluate the 
prevalence of HRV disease (5). As a result, the number 
of outbreaks caused by HRV in long-term care facilities, 
and the associated illness and death, may be substantially 
underestimated. We therefore used 2009 surveillance data 
to estimate prevalence of HRV disease in long-term care 
facilities.
The Study
Using data from an active surveillance network, we in-
vestigated all respiratory outbreaks (as deﬁ  ned by the Min-
istry of Health) (9), in long-term care facilities, reported 
from July 1 through December 31, 2009, in the province 
of Ontario, Canada. The number and timing of specimens 
collected was left to the discretion of the attending physi-
cians. The regional clinical laboratories cultured specimens 
(blood, urine, and sputum) for bacteria and performed 
rapid viral antigen testing for inﬂ  uenza A/B and RSV. The 
Ontario Public Health Laboratory performed reference 
microbiology testing that included Legionella culture, My-
coplasma/Chlamydophila nucleic acid testing (NAT), and 
virus cultures. Multiplex NAT (Luminex xTAG Respira-
tory Viral Panel; Luminex Diagnostics, Toronto, Ontario, 
Canada) was used according to the manufacturer’s recom-
mendations to test nasopharyngeal swabs for viral patho-
gens (adenovirus, inﬂ  uenza A/B, parainﬂ  uenzae 1–4, RSV 
A/B, enterovirus [ENT]/HRV, coronavirus OC43/229E/
NL63/HKU1, and metapneumovirus). An assay speciﬁ  c 
for pandemic (H1N1) 2009 virus was also performed.
To facilitate turnaround time during periods of higher 
demand, we used an alternate multiplex NAT kit (Seeplex 
RV; Seegene USA, Rockville, MD, USA) in conjunction 
with the Luminex assay. Because the Luminex assay can-
not differentiate between ENT and HRV, we used the See-
plex RV kit, which can identify HRV, to conﬁ  rm results in 
a random subset of ENT/HRV-positive samples. To type 
the HRV implicated in outbreaks during which deaths oc-
curred, we ampliﬁ  ed and sequenced the hypervariable re-
gion of the 5′ noncoding region, the entire viral capsid pro-
tein (VP) 4 gene, and the 5′ terminus of the VP2 gene; we 
then constructed phylogenetic trees as described (10,11).
During the surveillance period, 297 respiratory disease 
outbreaks in long-term care facilities were reported to the 
Ontario Public Health Laboratory; we received samples 
from 269 facilities (Table 1). A total of 987 specimens were 
tested (average 3.7 samples/outbreak). Of the 234 (79%) 
outbreaks for which a pathogen was identiﬁ  ed, 174 (59%) 
pathogens were determined to be ENT/HRV (representing 
531 positive samples) and were temporally spread through-
out the surveillance period. Pandemic (H1N1) 2009 virus 
and parainﬂ  uenza-1 virus represented 7% and 6%, respec-
tively, of identiﬁ  ed pathogens. Other viruses were identi-
ﬁ  ed for <2% of outbreaks. Viral co-infection was identiﬁ  ed 
in 7 samples from 7 outbreaks. A subset of 66 samples, 
representing 15% of ENT/HRV outbreaks, were randomly 
selected and subsequently tested with the Seeplex RV kit to 
further differentiate ENT from HRV; HRV was detected in 
100% of these specimens.
Deaths were potentially associated with ENT/HRV 
in 4 facilities (outbreaks A–D; Table 2). Samples from 
patients involved in these outbreaks were conﬁ  rmed  to 
contain HRV; no other causative bacteria or viruses were 
identiﬁ  ed. Clinical data were available for 7 of 13 of the 
patients who died; 6 deaths were attributed to pneumonia/
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Quebec City, Quebec, Canada. respiratory infection. Of the 7 patients who died, 5 (71%) 
had osteoarthritis, 4 (57%) had cardiovascular conditions, 
4 (57%) had dementia, 2 (29%) had diabetes, and 1 (14%) 
had cancer. The only postmortem lung tissue specimen col-
lected was positive for HRV-C (outbreak D).
Nucleotide sequences obtained from isolates from 
outbreaks A, B, C, and D showed homology to HRV-A 
31 (92%), HRV-A 33 (93%), HRV-A 82 (91%), and 
HRV-C N7 (90%), respectively. We performed multiple 
sequence alignments of the 410 bp of the 5′ untranslated 
region, VP4/VP2, and VP1 and compared them with 66 
published representative HRV sequences. We could not 
obtain a VP1 sequence from strains isolated during out-
break D. Phylogenic trees were constructed, and the VP4/
VP2 region tree showed better discriminatory power than 
did that of the 5′ untranslated region (Figure). VP4/VP2 
sequence identity was >98% within each outbreak. Se-
quences were deposited in GenBank under accession nos. 
GU477323–GU477344.
Conclusions
We cautiously assume that HRV was the causative or-
ganism for 174 (59%) of the 297 respiratory outbreaks in 
long-term care facilities in Ontario during the surveillance 
period. Multiplex molecular methods were crucial for rapid 
identiﬁ  cation of the pathogens involved in these outbreaks. 
We were able to provide results in a timely fashion for ev-
ery outbreak. However, the cost and expertise associated 
with such technology might be beyond the reach of some 
clinical laboratories. Because of the limitations of the sur-
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Table 1. Viruses identified in 297 respiratory illness outbreaks in 
long-term care facilities, Ontario, Canada, July 1–December 31, 
2009*
Virus  Outbreaks, no. (%) 
Enterovirus/rhinovirus 174 (59.0) 
Influenza A  22 (7.0) 
Parainfluenza 1  18 (6) 
Parainfluenza 2  3 (1.0) 
Parainfluenza 3  3 (1.0) 
Parainfluenza 4  2 (0.7) 
Metapneumovirus 2 (0.7) 
Influenza B  1 (0.3) 
Respiratory syncytial virus A  1 (0.3) 
Respiratory syncytial virus B  1 (0.3) 
Adenovirus 0
No specimens received  28 (9.0) 
Negative 63 (21.0) 
*In 187 outbreaks, 1 virus was detected; in 17 outbreaks, 2 viruses were 
detected; and in 3 outbreaks, 3 viruses were detected. 
Table 2. Epidemiologic data for rhinovirus outbreaks associated with deaths in long-term care facilities, Ontario, Canada, July 1–
December 31, 2009 
Outbreak 
No. sick residents/total no. 
residents (%)  No. deaths 
No. sick staff members/total no. 
staff members (%)  Outbreak duration, d 
HRV species and 
strain* 
A 28/59 (47)  1 16/80 (20)  38 HRV-A 31 
B 32/60 (53)  7 21/100 (21)  43 HRV-A 33 
C 19/158 (12)  3 1/200 (0.5)  20 HRV-A 82 
D 23/115 (20)  2 3/134 (2)  12 HRV-C N7 
*HRV, human rhinovirus. 
Figure. Neighbor-joining phylogenetic tree of human rhinoviruses 
(HRV) isolated from 4 respiratory disease outbreaks with 
associated deaths in long-term care facilities, Ontario, Canada. 
Tree was constructed by using a 549-bp nt region encoding viral 
capsid protein (VP) 4/VP2, along with strains representative of HRV 
species A, B, and C. Echo 11 is the outgroup. Bootstrap analysis 
used 1,000 pseudoreplicate datasets. Scale bar represents 0.1% 
of nucleotide changes between close relatives. Boldface indicates 
sequences deposited in GenBank.Rhinovirus Outbreaks in Long-term Care Facilities
veillance program, we were unable to assess whether such 
testing is cost-effective in terms of patient care. 
Of the 4 outbreaks with associated deaths, 3 were at-
tributed to HRV-A and 1 to HRV-C. The link between respi-
ratory disease severity and HRV-C speciation is debatable 
(12). In a study from Hong Kong, 8 (62%) of 13 adults with 
HRV-C infection had pneumonia compared with 6 (27%) of 
22 adults with HRV-A infection (13). However, in the cases 
we studied, most deaths were associated with HRV-A; a re-
cent study found that HRV-C disease had the same indistinct 
clinical presentation as did other HRV diseases (14).
Viruses isolated from nasopharyngeal swabs by sen-
sitive NAT may represent asymptomatic colonization or 
nonliving organisms. Although postmortem specimens 
were available for analysis from only 1 outbreak-related 
case, we identiﬁ  ed HRV in the postmortem lung speci-
men. Because we do not know whether HRV was present 
in the lower respiratory tract of the remaining patients who 
died, a causal association between HRV and severe disease 
must be made cautiously. We used the 2 NAT assays inter-
changeably because their reported speciﬁ  city is >96% for 
all targets (15). Sensitivity for each assay differs accord-
ing to target; compared with the Luminex assay, Seeplex 
RV is more sensitive for parainﬂ  uenza, RSV, coronavirus, 
and adenovirus but less sensitive for HRV (15). However, 
despite limitations for epidemiologic data collection, no 
pathogens other than HRV could explain these outbreaks 
and associated deaths. Our testing panel did not include 
human bocavirus or inﬂ  uenza C virus, which could be in-
volved in the remaining 21% of outbreaks that had no iden-
tiﬁ  ed cause and could even represent confounding factors 
in the causal relationship of a supposed pathogen.
In conclusion, using data from a routine surveillance 
network, we found high prevalence of HRV during a period 
that encompassed the ﬁ  rst and second waves of pandemic 
(H1N1) 2009. These ﬁ  ndings are in accordance with the in-
creasing knowledge that HRV outbreaks cause severe and 
fatal disease.
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